Dollvet joins East Africa’s Foot-and-Mouth Disease Vaccine Project
Author: Staff WriterPublished on: November 19, 2026Country: Tanzania
HealthScienceWorld / International

In November 2026, Turkish veterinary vaccine manufacturer Dollvet joined the AgResults project for foot-and-mouth disease vaccines in Eastern Africa. After registering a quadrivalent vaccine in Ethiopia that meets the project’s Target Product Profile and securing approval from its Judging Panel, Dollvet entered the vaccine distribution cost-share phase. It joins Biopharma and Boehringer Ingelheim, which entered the competition in 2025 and 2026, respectively. Launched in 2020 with a US$17.34 million prize fund, the project aims to develop and distribute high-quality vaccines suited to the region.
Read original article
tanzaniatimes.netStay informed with NewsBoulevard
Get the latest news summaries delivered to your inbox


